Psychiatry Res 2018;263:268-74
This lizard spends up to 95% of its life underground in the Arizona desert, and it's the reason this class of drugs exist
Exenatide, and in particular its extended-release (ER) formulation, is the GLP-1 receptor agonist with the broadest clinical evidence, including motor and cognitive improvements in an open-label phase 2 study [161] which persisted 12 months after drug withdrawal [162], as well as motor improvement in a placebo-controlled phase 2 trial [163]
While those changes can support weight-management goals, they can also affect how much fluid people naturally consume
According to WHO, tobacco kills up to half of its users who dont quit, totalling more than 7 million people annually, including an estimated 1.6 million non-smokers who are exposed to second-hand smoke
The FDAs Orange Book formally titled Approved Drug Products with Therapeutic Equivalence Evaluations sits at the center of pharmaceutical IP strategy because it determines which patents can trigger the Hatch-Waxman automatic 30-month stay of generic approval